Medirom Healthcare Technologies Inc. (MRM) stock

MRMNasdaqServices-Personal ServicesFiscal year ends December 31

Financials through fiscal 2024, year ended Dec 31, 2024

$0.28−0.01 (-2.33%)

Close on Nov 13, 2026Market cap $2.19MP/E 1.5Yield –

Medirom Healthcare Technologies r&d expenses

Research and development expenses are spending on new products and technology.

Medirom Healthcare Technologies has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Medirom Healthcare Technologies's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MRM.

Revenue growth21.5% · median 3.0%

Gross margin27.1% · median 43.7%

Operating margin-0.2% · median 10.4%

Net margin1.8% · median 8.3%

Advertisement
300 × 250

See a number that looks wrong?